Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system, phosphoinositide-3-kinase and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development.
| There are currently no events scheduled. |
May 22, 2013
Infinity to Present at Deutsche Bank's 38th Annual Health Care Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 22, 2013--
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at
Deutsche Bank's 38th Annual Health Care Conference on May 29,
2013, at 4:15 p.m. ET in Boston, MA.
A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.
About Infinity Pharmaceutica
May 15, 2013
Infinity Announces Clinical Data to Be Presented at ASCO and ICML
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 15, 2013--
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Phase
1 clinical data for IPI-145, its potent, oral inhibitor of
phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, will be presented
at the 49th Annual Meeting of the American Society of
Clinical Oncology (ASCO), which is being held from May 31 through June 4
in Chicago, Ill., and the 12th International Conference on
Malignant
May 14, 2013
Infinity to Present at the UBS Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 14, 2013--
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
UBS Global Healthcare Conference on May 21, 2013, at 12:30 p.m. ET in
New York.
A live webcast of Infinity's presentation will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
